Aptar Pharma Discusses with Forbes its Expanded Partnership with Propeller Health to Deliver Connected Medicines

A recent article on Forbes.com discusses the significance of Aptar Pharma’s expanded relationship with Propeller Health to deliver Connected Medicines across multiple therapeutic areas. Announced May 30, this partnership, which includes a strategic equity investment by Aptar Pharma in Propeller Health, is “a move that signals the pharmaceutical industry’s growing interest in digital therapeutics.”
To find out more, read the full article: https://bit.ly/2xvfwxS